Post-Transplant Diabetes Mellitus (PTDM) in Heart Recipients
Miroslaw GarlickiAnn Transplant 2005; 10(3): 51-53 :: ID: 496213
Abstract
Diabetes mellitus is a metabolic disorder that is prevalent in the general population, with more than one in five people over 50 years of age presenting with the condition [Van Hooff 2004].In general, (post-transplant) diabetes develops as a result of low or absent insulin output, increased insulin resistance, or a combination of the two. Transplant recipients generally take a combination of immunosuppressive drugs. Not only the calcineurin inhibitors cyclosporine and tacrolimus, but also corticosteroids have been associated with disturbances in glucose metabolic control [Van Dujinhoven 2003]. PTDM shares many similarities with type 2 diabetes and it may be reversible [Davidson et al. 2003]. The incidence of PTDM after heart transplantation is generally higher when compared to other organ transplantations [ISHLT 2004]....
Keywords: Post-Transplant
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860